References

1. Gertz MA, Kyle RA: Hyperviscosity syndrome. J Intens Care Med 10(3):128-141, 1995 May-Jun.

2. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62(8): 719-731, 1987 Aug.

3. Pickart LR, Thaler MM: Fatty acids, fibrinogen and blood flow: a general mechanism for hyperfibrinogenemia and its pathologic consequences. Med Hypotheses 6(5): 545-557, 1980 May.

4. Richardson SG, Matthews KB, Cruickshank JK, Geddes AM, Stuart J: Coagulation activation and hyperviscosity in infection. Br J Haematol 42(3):469-480, 1979 Jul.

5. Eckmann DM, Bowers S, Strecker M, Cheung AT: Hematocrit, volume expander, temperature, and shear rate effects on blood viscosity. Anesth Analg 91(3): 539-545, 2000 Sep.

6. Koppensteiner R: Blood rheology in emergency medicine. Semin Thromb Hemost 22(1):89-91, 1996.

7. Somer T, Meiselman HJ: Disorders of blood viscosity. Ann Med 25(1):31-39, 1993 Feb.

8. Gordge MP, Patel A, Faint RW, Rylance PB, Neild GH: Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy. DiabetMed 7(10):880-886, 1990 Dec.

9. Merlini G, Baldini L, Broglia C, et al.: Prognostic factors in symptomatic Waldenstrom's macroglobulinemia. Semin Oncol 30(2):211-215, 2003 Apr.

10. Kopp WL, Beirne GJ, Burns RO: Hyperviscosity syndrome in multiple myeloma. Am J Med 43(1):141-146, 1967 Jul.

11. Lindsley M, Teller D, Noonan B, Peterson M, Mannik M: Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein. Am J Med 54(4):682-688, 1973 May.

12. Tuddenham EGD, Whittaker JA, Bradley JS, Lilleyman JS, James DR: Hyperviscosity syndrome in IgA multiple myeloma. Br J Haematol 27:65-76, 1974.

13. Jensen KB: Metabolism of human 7-macroglobulin (IGM) in normal man. Scand J Clin Lab Invest 24:205, 1969.

14. Johnson SA: Waldenstrom's macroglobulinemia. Rev Clin Hematol 6(4):421-434, 2002 Dec.

15. Ballas SK: The erythrocyte sedimentation rate, rouleaux formation and hyperviscosity syndrome. Theory and fact. Am J Clin Pathol 63(1):45-48, 1975 Jan.

16. Fahey JL, Barth WF, Solomon A: Serum hyperviscosity syndrome. JAMA 192:464-467, 1965.

17. Crawford J, Cox EB, Cohen HJ: Evaluation of hyperviscosity in monoclonal gammopathies. Am J Med 79(1): 13-22, 1985 Jul.

18. Russel JA, Powles RL: The relationship between serum viscosity, hypervolemia and clinical manifestations associated with circulating paraprotein. Br J Haematol 39(2): 163-175, 1978 Jun.

19. Capra JD, Kunkel HG: Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome. J Clin Invest 49(3):610-621, 1970 Mar.

paraprotein (e.g., immunoglobulin-related neuropathy) rather than tumor burden.14

20. Castleman B, Scully RE, McNeely BU: Case records of the Massachusetts General Hospital. Weekly clinicopatho-logical exercises. N Engl J Med 34:213, 1972.

21. Dine ME, Guay AT, Snyder LM: Hyperviscosity syndrome with IgA myeloma. Am J Med Sci 264(2):111-115, 1972 Aug.

22. Wolf RE, Alperin JB, Ritzmann SE, Levin WC: IgG-K-multiple myeloma with hyperviscosity syndrome— response to plasmapheresis. Arch Intern Med 129(1): 114-117, 1972 Jan.

23. Mannik M: Blood viscosity in Waldenstrom's macroglobulinemia. Blood 44(1):87-98, 1974 Jul.

24. MacKenzie MR, Lee TK: Blood viscosity in Waldenstrom macroglobulinemia. Blood 49(4):507-510, 1977 Apr.

25. Deuel TF, Davis P, Avioli LV: Waldenstrom's macroglobulinemia. Arch Intern Med 143(5):986-988, 1983 May.

26. McCallister BD, Bayrd ED, Harrison EG, Mc Guckin WF: Primary macroglobulinemia: review with a report of thirty-one cases and notes on the value of continous chlorambucil therapy. Am J Med 43:394-434, 1967.

27. Martin NH: Macroglobulinemia. A clinical and pathological study. Q J Med 29:179-197, 1960 Apr.

28. Luxenberg MN, Mausolf FA: Retinal circulation in the hyperviscosity syndrome. Am J Ophthalmol 70(4): 588-598, 1970 Oct.

29. Dobberstein H, Solbach U, Weinberger A, Wolf S: Correlation between retinal microcirculation and blood viscosity in patients with hyperviscosity syndrome. Clin Hemorheol Microcirc 20:31-35, 1999.

30. Menke MN, Feke GT, McMeel JW, Branagan A, Hunter Z, Treon SP: Hyperviscosity-related retinopathy in Waldenstrom's macroglobulinemia. Arch Ophthalmol

In press.

31. Goen TM, Terry JE: Mid-peripheral hemorrhages secondary to Waldenstrom's macroglobulinemia. J Am Optom Assoc 57(2):109-112, 1986 Feb.

32. Thomas EL, Olk RJ, Markman M, Braine H, Patz A: Irreversible visual loss in Waldenstrom's macroglobu-linemia. Br J Ophthalmol 67(2): 102-106, 1983 Feb.

33. Grindle CF, Buskard NA, Newman DL: Hyperviscosity retinopathy. A scientific approach to therapy. Trans Ophthalmol Soc UK 96(2):216-219, 1976 Jul.

34. Orellana J, Friedman AH: Ocular manifestations of multiple myeloma, Waldenstrom's macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol 26(3):157-169, 1981 Nov-Dec.

35. Gertz MA, Fonseca R, Rajkumar SV: Waldenstrom's macroglobulinemia. Oncologist 5(1):63-67, 2000.

36. Blumenthal DT, Glenn MJ: Neurologic manifestations of hematologic disorders. Neurol Clin 20(1):265-281, 2002 Feb.

37. Syms MJ, Arcila ME, Holtel MR: Waldenstrom's macroglobulinemia and sensorineural hearing loss. Am J Otolaryngol 22(5):349-353, 2001 Sep-Oct.

38. Bernath I, Bernat I, Pongracz E, Koves P, Szakacs Z, Horvath A: Effects of blood hyperviscosity on functional intergrity in the brain stem: a brain stem evoked auditory potential study. Clin Hemorheol Microcirc 31(2): 123-128, 2004.

39. Goldstein M, Stonestreet BS, Brann BS IV, Oh W: Cerebral cortical blood flow and oxygen metabolism in normocythemic hyperviscous newborn piglets. Pediatr Res 24(4):486-489, 1988 Oct.

40. Rosenblum WI: Erythrocyte velocity and fluorescein transit time in the cerebral microcirculation of macroglobulinemic mice: differential effect of a hyper-viscosity syndrome on the passage time of erythrocytes and plasma. Microvasc Res 3(3):288-296, 1971 Jul.

41. Simchon S, Chen RY, Carlin RD, Fan FC, Jan KM, Chien S: Effects of blood viscosity on plasma renin activity and renal hemodynamics. Am J Physiol 250:F40-F46, 1986 Jan.

42. McDonald KM: Influence of blood rheology on intrarenal blood flow distribution. Am J Physiol 230(5):1448-1454, 1976 May.

43. Wong PN, Mak SK, Lo KY, Tong GM, Wong AK: Acute tubular necrosis in a patient with Waldenstrom's macroglobulinemia and hyperviscosity syndrome. Nephrol Dial Transplant 15(10):1684-1687, 2000 Oct.

44. Gertz MA, Anagnostopoulos A, Anderson K, et al.: Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30(2):121-126, 2003 Apr.

45. Feman SS, Stein RS: Waldenstrom's macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy. Int Ophthalmol 4(1-2):107-112, 1981 Aug.

46. Freidman AH, Marchevsky A, Odel JG, Gerber MA, Thung SN: Immunofluorescent studies of the eye in Waldenstrom's macroglobulinemia. Arch Ophthalmol 98(4):743-746, 1980 Apr.

47. Reinhart WH, Lutolf O, Nydegger UR, Mahler F, Straub PW: Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenstrom and multiple myeloma: influence on blood rheology and the microcirculation. J Lab Clin Med 119(1):69-76, 1992 Jan.

This page intentionally left blank

0 0

Post a comment